Keith Muckenhirn - Antares Pharma Vice President - Finance, Corporate Controller
| ATRSDelisted Stock | USD 5.59 0.00 0.00% |
President
Mr. Keith Muckenhirn serves as Interim Chief Financial Officer Principal Accounting Officer Principal Financial Officer Corporationrationrate Controller of the Company. He is the Companys Vice President Finance and Corporationrationrate Controller since 2011. Mr. Muckenhirn joined the Company in 2001 as Controller and has more than 30 years of experience in accounting and financial reporting. since 2016.
| Age | 52 |
| Tenure | 8 years |
| Phone | 609 359-3020 |
| Web | www.antarespharma.com |
Antares Pharma Management Efficiency
The company has return on total asset (ROA) of 7.27 % which means that it generated a profit of $7.27 on every $100 spent on assets. This is normal as compared to the sector avarege. Similarly, it shows a return on stockholder's equity (ROE) of 31.4 %, meaning that it created $31.4 on every $100 dollars invested by stockholders. Antares Pharma's management efficiency ratios could be used to measure how well Antares Pharma manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 25.22 M in liabilities with Debt to Equity (D/E) ratio of 0.14, which may suggest the company is not taking enough advantage from borrowing. Antares Pharma has a current ratio of 2.9, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Antares Pharma until it has trouble settling it off, either with new capital or with free cash flow. So, Antares Pharma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Antares Pharma sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Antares to invest in growth at high rates of return. When we think about Antares Pharma's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Jan Zijderveld | Unilever PLC ADR | 52 | |
| Sunny Jain | Unilever PLC ADR | 45 | |
| Nitin Paranjpe | Unilever PLC ADR | 61 | |
| Antoine SaintAffrique | Unilever PLC ADR | 51 | |
| Takeo Kudo | NH Foods Ltd | N/A | |
| Lillian Barlett | SunOpta | 53 | |
| Amanda Sourry | Unilever PLC ADR | 54 | |
| Richard Simms | Rocky Brands | 50 | |
| Rohit Jawa | Unilever PLC ADR | N/A | |
| Juichi Suezawa | NH Foods Ltd | 62 | |
| Takahito Ohkoso | NH Foods Ltd | N/A | |
| Kevin Havelock | Unilever PLC ADR | 59 | |
| Courtland Pearson | Lifevantage | N/A | |
| Hiroji Ohkoso | NH Foods Ltd | 62 | |
| Michelle ObornVirchow | Lifevantage | 44 | |
| Jill Barnett | SunOpta | 50 | |
| Yoshihide Hata | NH Foods Ltd | 65 | |
| Gary Adam | Rocky Brands | 52 | |
| Gerard Versteegh | SunOpta | 54 | |
| James Gratzek | SunOpta | 51 | |
| Hanneke Faber | Unilever PLC ADR | 51 | |
Management Performance
| Return On Equity | 31.4 | |||
| Return On Asset | 7.27 |
Antares Pharma Leadership Team
Elected by the shareholders, the Antares Pharma's board of directors comprises two types of representatives: Antares Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Antares. The board's role is to monitor Antares Pharma's management team and ensure that shareholders' interests are well served. Antares Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Antares Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Thomas Garrity, Independent Director | ||
| Eamonn Hobbs, CEO and President and Director | ||
| Marvin Samson, Director | ||
| Leonard Jacob, Independent Chairman of the Board | ||
| Jacques Gonella, Independent Director | ||
| James Fickenscher, CFO and Sr. VP | ||
| Fred Powell, CFO, Senior Vice President Principal Financial Officer and Principal Accounting Officer | ||
| Robert Apple, CEO and Pres | ||
| Jack Howarth, IR Contact Officer | ||
| Keith Muckenhirn, Vice President - Finance, Corporate Controller | ||
| Peter Graham, Chief Compliance Officer, Head of HR, Sr. VP, General Counsel and Corporate Secretary | ||
| Robert Roche, Director | ||
| Anton Gueth, Independent Director |
Antares Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Antares Pharma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 31.4 | |||
| Return On Asset | 7.27 | |||
| Profit Margin | 25.16 % | |||
| Operating Margin | 14.86 % | |||
| Current Valuation | 904.7 M | |||
| Shares Outstanding | 170.04 M | |||
| Shares Owned By Insiders | 7.56 % | |||
| Shares Owned By Institutions | 60.38 % | |||
| Number Of Shares Shorted | 7.28 M | |||
| Price To Earning | 14.95 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Antares Pharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Antares Pharma's short interest history, or implied volatility extrapolated from Antares Pharma options trading.
Pair Trading with Antares Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Antares Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Antares Pharma will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Antares Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Antares Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Antares Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Antares Pharma to buy it.
The correlation of Antares Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Antares Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Antares Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Antares Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in Antares Stock
If you are still planning to invest in Antares Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Antares Pharma's history and understand the potential risks before investing.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |